Multi-infarct dementia

Multi-infarct dementia
Classification and external resources
ICD-10 F01.1
ICD-9 290.4
DiseasesDB 8393
eMedicine med/3150 neuro/227
MeSH D015161

Multi-infarct dementia is one type of vascular dementia. Vascular dementia is the second most common form of dementia after Alzheimer's disease (AD) in older adults.[1] Multi-infarct dementia (MID) is thought to be an irreversible form of dementia, and its onset is caused by a number of small strokes or sometimes, one large stroke preceded or followed by other smaller strokes.[2] The term refers to a group of syndromes caused by different mechanisms all resulting in vascular lesions in the brain. Early detection and accurate diagnosis are important, as vascular dementia is at least partially preventable.

The main subtypes of this disease are: mild cognitive impairment, multi-infarct dementia, vascular dementia due to a strategic single infarct (affecting the thalamus, the anterior cerebral artery, the parietal lobes or the cingulate gyrus), vascular dementia due to hemorrhagic lesions, and mixed Alzheimer's and vascular dementia.

Vascular lesions can be the result of diffuse cerebrovascular disease or focal lesions; usually both. Mixed dementia is diagnosed when patients have evidence of AD and cerebrovascular disease, either clinically or based on neuroimaging evidence of ischemic lesions. In fact vascular dementia and Alzheimer's disease often coexist, especially in older patients with dementia.

Contents

Signs and symptoms

MID and AD, despite the fact that the two organic disorders have different causes, can be almost impossible to tell apart clinically and are often misdiagnosed.[3] Patients suffering from vascular dementia present with cognitive impairment, acutely or subacutely, after an acute cerebrovascular event. After the onset a stepwise progression is typical.

In small vessel disease the incidence peaks between the 4th and the 7th decades of life and 80% will have a history of hypertension. Patients develop progressive cognitive, motor and behavioral signs and symptoms. A significant proportion of them also develop affective symptoms. These changes occur over a period of 5–10 years. If the frontal lobes are affected, which is often the case, patients may present as apathetic or abulic. This is often accompanied by problems with attention, orientation and urinary incontinence.

As already stated, small vessel disease and focal lesions often overlap, so these two patterns may be evident in the same individual concurrently.

Rare genetic disorders which result in vascular lesions in the brain have other patterns of presentation. As a rule of thumb they tend to present earlier in life and have a more aggressive course.

Diagnosis

Several specific diagnostic criteria can be used to diagnose vascular dementia,[4] including the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria, the International Classification of Diseases, Tenth Edition (ICD-10) criteria, the National Institute of Neurological Disorders and Stroke- Association Internationale pour la Recherche et l'Enseignement en Neurosciences (NINDS-AIREN) criteria,[5] the Alzheimer's Disease Diagnostic and Treatment Center criteria, and the Hachinski ischemic score.[6]

Lateralizing signs such as hemiparesis, bradykinesia, hyperreflexia, extensor plantar reflexes, ataxia, pseudobulbar palsy, and gait and swallowing difficulties may be observed.

In terms of cognitive testing patients have patchy deficits. They tend to have better free recall and fewer recall intrusions compared with patients with Alzheimer's disease. As small vessel disease often affects the frontal lobes, apathy early in the disease is more suggestive of vascular dementia because it usually occurs in the later stages of Alzheimer's. Consequently patients with vascular dementia perform worse than their Alzheimer's disease counterparts in frontal lobe tasks such as verbal fluency. They also tend to exhibit more perseverative behavior. They may also present with general slowing of processing ability, difficulty shifting sets and impairment in abstract thinking. In the more severe patients, or those patients affected by strategic infarcts in the Wernicke or Broca areas, dysarthrias, dysphasias and aphasias may be present.

The recommended investigations for cognitive impairment should be carried out, including a dementia screening blood test, chest X-Ray, CAT scan and ECG. The screening blood test should typically include full blood count, liver function tests, thyroid function tests, lipid profile, erythrocyte sedimentation rate, C reactive protein, syphilis serology, calcium serum level, fasting glucose, urea and electrolytes, vitamin B-12, folate. In selected patients HIV serology and autoantibody testing may be done.

Cause

Risk factors for vascular dementia include hypertension, smoking, hypercholesterolemia, diabetes mellitus, and cardiovascular disease and cerebrovascular disease.

Treatment

The aim of the management is the prevention of further cerebrovascular lesions. This includes administering antiplatelet drugs and controlling major vascular risk factors (hypertension, hypercholesterolemia, smoking and diabetes mellitus to mention a few).

The general management of dementia includes referral to community services, judgment and decision-making regarding legal and ethical issues (e.g., driving, capacity, advance directives), and consideration of caregiver stress.

Cholinesterase inhibitors such as galantamine have shown to be helpful in various randomized controlled trials. However their use is not licensed yet for this indication.

Behavioral and affective symptoms are particularly important in this patient group and deserve special consideration. These problems, if they develop, tend to be resistant to conventional psychopharmacological treatment and in many cases lead to hospital admission and placement in permanent care.

Prognosis

The 5-year survival rate is 39% for patients with vascular dementia compared with 75% for age-matched controls. Vascular dementia is associated with a higher mortality than "Alzheimer's", presumably because of the excess in cardiovascular risk factors.

Epidemiology

Vascular dementia is the second most common cause of dementia in the United States and Europe in the elderly, but it is the most common form in some parts of Asia. The prevalence of the illness is 1.5% in Western countries and approximately 2.2% in Japan. It accounts for 50% of all dementias in Japan, 20% to 40% in Europe and 15% in Latin America. The incidence of dementia is 9 times higher in patients who have had a stroke than in controls. 25% of stroke patients develop new-onset dementia within 1 year of their stroke. The relative risk of incident dementia is 5.5% within 4 years of suffering a stroke.

The prevalence of vascular dementia is higher in men than in women and it increases with age.

See also

References

  1. ^ "Vascular Dementia: A Resource List". http://www.nia.nih.gov/Alzheimers/Publications/vascular.htm. 
  2. ^ Antai-Otong, D. 2008. Psychiatric Nursing: Biological and Behavioral Concepts. 2nd ed. Canada: Thompson Delmar Learning.
  3. ^ Marks, D. and Sykes, C. 2000. Dealing with Dementia: Recent European Research. London: Middlesex University Press.
  4. ^ Wetterling T, Kanitz RD, Borgis KJ (January 1996). "Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN)". Stroke 27 (1): 30–6. PMID 8553399. http://stroke.ahajournals.org/cgi/pmidlookup?view=long&pmid=8553399. 
  5. ^ Tang W, Chan S, Chiu H, Ungvari G, Wong K, Kwok T, Mok V, Wong K, Richards P, Ahuja A (2004). "Impact of applying NINDS-AIREN criteria of probable vascular dementia to clinical and radiological characteristics of a stroke cohort with dementia". Cerebrovasc. Dis. 18 (2): 98–103. doi:10.1159/000079256. PMID 15218273. 
  6. ^ Pantoni L, Inzitari D (1993). "Hachinski's ischemic score and the diagnosis of vascular dementia: a review". Italian journal of neurological sciences 14 (7): 539–46. doi:10.1007/BF02339212. PMID 8282525. 

External links


Wikimedia Foundation. 2010.

Look at other dictionaries:

  • Multi-infarct dementia — Dementia brought on by a series of * * * mul·ti in·farct dementia in .färkt , in färkt n irreversible dementia that results from a series of small strokes in which cerebral infarction occurs and in which mental deterioration is usu. characterized …   Medical dictionary

  • Dementia with Lewy bodies — Classification and external resources Lewy bodies are the pathophysiological characteristic of the disease ICD 10 G …   Wikipedia

  • Dementia — Significant loss of intellectual abilities such as memory capacity, severe enough to interfere with social or occupational functioning. Criteria for the diagnosis of dementia include impairment of attention, orientation, memory, judgment,… …   Medical dictionary

  • Dementia — For other uses, see Dementia (disambiguation). Dementia Classification and external resources ICD 10 F00 F07 ICD 9 …   Wikipedia

  • dementia — n. a chronic and progressive deterioration of behaviour and higher intellectual function due to organic brain disease. It is marked by memory disorders, changes in personality, deterioration in personal care, impaired reasoning ability, and… …   The new mediacal dictionary

  • dementia — demential, adj. /di men sheuh, shee euh/, n. Psychiatry. severe impairment or loss of intellectual capacity and personality integration, due to the loss of or damage to neurons in the brain. [1800 10; < L dementia madness, equiv. to dement out of …   Universalium

  • arteriosclerotic dementia — multi infarct dementia as a result of cerebral arteriosclerosis …   Medical dictionary

  • vascular dementia — n dementia (as multi infarct dementia) of abrupt or gradual onset that is caused by cerebrovascular disease * * * [DSM IV] dementia with a stepwise deteriorating course (a series of small strokes) and a patchy distribution of neurologic deficits… …   Medical dictionary

  • Alzheimer's disease — Alzheimer redirects here. For other uses, see Alzheimer (disambiguation). Alzheimer s disease Classification and external resources …   Wikipedia

  • Alzheimer's disease clinical research — As of August 2010 there were more than 800 clinical trials under way to understand and treat Alzheimer s disease. 149 of these studies were human phase three trials, the last step before U.S. Food and Drug Administration approval and marketing.… …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.